Medicine News and Research

RSS

Study reveals the global economic costs of diabetes

Diabetes mellitus is a chronic metabolic disorder and one of the most prevalent non-communicable diseases worldwide.

9 Jan 2026

Single-cell analysis illuminates myeloma immune landscape

Scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research Foundation (MMRF) and in collaboration with leading institutions across the country, have helped generate the largest single-cell immune cell atlas of the bone marrow in patients with multiple myeloma, a blood cancer that, while treatable, remains incurable.

9 Jan 2026

Maternal whooping cough vaccine shields newborns' immune system

In 2024, Germany recorded the highest number of whooping cough cases since reporting became mandatory in the year 2013.

9 Jan 2026

Research shows benefits of lifestyle interventions in reducing the risk of gestational diabetes

New research co-authored by Professor Fionnuala McAuliffe, UCD School of Medicine, and led by the University of Liverpool, has demonstrated the significant benefits of lifestyle interventions in reducing the risk of gestational diabetes.

9 Jan 2026

Breastfeeding linked to lower long-term depression and anxiety in mothers

Breastfeeding may lower mothers' later life risks of depression and anxiety for up to 10 years after pregnancy, suggest the findings of an observational study, BMJ Open' page">published in the open access journal BMJ Open.

9 Jan 2026

Self-administered injectable contraceptives face provider hesitancy despite availability

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a quarter of reproductive health experts prescribe it - and many are unaware it's even an option.

9 Jan 2026

Long-term diabetes changes red blood cells, increasing cardiovascular disease risk

The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood cells may be an important explanation, and identifies a specific molecule as a possible biomarker.

9 Jan 2026

Immune cell atlas may improve survival predictions, guide treatment decisions in multiple myeloma

aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure.

9 Jan 2026

New research decodes the bacterial “zip code” of colorectal cancer for prediction and survival

Bacterial communities in colorectal cancer reveal patterns linked to tumor genetics and patient outcomes, paving the way for personalized treatment strategies.

From BGI Genomics 9 Jan 2026

California ends Medicaid coverage of weight loss drugs despite TrumpRx plan

Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year.

9 Jan 2026

Global analysis shows widespread eligibility for GLP-1 weight management drugs

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers.

8 Jan 2026

UCLA awarded major state funding to advance comprehensive cannabis research

UCLA has received four grants totaling $7.3 million from the California Department of Cannabis Control (DCC) to support research on a broad range of topics, from the therapeutic potential of cannabinoids to the cardiovascular risks of cannabis use and strategies for addressing California's unregulated cannabis market.

8 Jan 2026

Real-time smartphone monitoring improves evaluation of insomnia treatment effectiveness

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and irritability as well as increased health risks like diabetes and heart risks if left untreated.

8 Jan 2026

Individualized drug combinations improve cancer treatment outcomes

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based on the unique DNA of a patient's tumor.

8 Jan 2026

$Neural pain pathways found to play crucial role in bone fracture healing$

Medicine News and Research

Study reveals the global economic costs of diabetes

Single-cell analysis illuminates myeloma immune landscape

Maternal whooping cough vaccine shields newborns' immune system

Research shows benefits of lifestyle interventions in reducing the risk of gestational diabetes

Breastfeeding linked to lower long-term depression and anxiety in mothers

Self-administered injectable contraceptives face provider hesitancy despite availability

Long-term diabetes changes red blood cells, increasing cardiovascular disease risk

Immune cell atlas may improve survival predictions, guide treatment decisions in multiple myeloma

New research decodes the bacterial “zip code” of colorectal cancer for prediction and survival

California ends Medicaid coverage of weight loss drugs despite TrumpRx plan

Global analysis shows widespread eligibility for GLP-1 weight management drugs

UCLA awarded major state funding to advance comprehensive cannabis research

Real-time smartphone monitoring improves evaluation of insomnia treatment effectiveness

Individualized drug combinations improve cancer treatment outcomes

Neural pain pathways found to play crucial role in bone fracture healing

Study reveals innate immune barriers to long-term pig kidney transplant survival

Study investigates the extent of flu transmission by airborne inhalation

Scientists discover how stem cells navigate and repair brain damage after stroke

Clonal hematopoiesis linked to increased heart disease risk in cancer patients receiving treatment

UBC researchers crack code to grow helper t cells from stem cells

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News